Last reviewed · How we verify
zidovudine-lamivudine-nevirapine
zidovudine-lamivudine-nevirapine is a Small molecule drug developed by University of California, San Diego. It is currently FDA-approved. Also known as: Retrovir, Epivir, Viramune.
At a glance
| Generic name | zidovudine-lamivudine-nevirapine |
|---|---|
| Also known as | Retrovir, Epivir, Viramune |
| Sponsor | University of California, San Diego |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV (PHASE2, PHASE3)
- A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments (PHASE4)
- Early Infant HIV Treatment in Botswana (PHASE2, PHASE3)
- Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen (PHASE2, PHASE3)
- Research on the Psychological Status of Patients With HIV-1 Infection
- A Study of Zidovudine/Lamivudine and Either Nevirapine or Nelfinavir for Reduction of Mother-to-child HIV Transmission During Breastfeeding (PHASE2)
- A Prospective Cohort of Children With HIV Infection
- ARVs to Prevent Breastmilk HIV:Viral and Immune Responses (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- zidovudine-lamivudine-nevirapine CI brief — competitive landscape report
- zidovudine-lamivudine-nevirapine updates RSS · CI watch RSS
- University of California, San Diego portfolio CI
Frequently asked questions about zidovudine-lamivudine-nevirapine
What is zidovudine-lamivudine-nevirapine?
zidovudine-lamivudine-nevirapine is a Small molecule drug developed by University of California, San Diego.
Who makes zidovudine-lamivudine-nevirapine?
zidovudine-lamivudine-nevirapine is developed and marketed by University of California, San Diego (see full University of California, San Diego pipeline at /company/university-of-california-san-diego).
Is zidovudine-lamivudine-nevirapine also known as anything else?
zidovudine-lamivudine-nevirapine is also known as Retrovir, Epivir, Viramune.
What development phase is zidovudine-lamivudine-nevirapine in?
zidovudine-lamivudine-nevirapine is FDA-approved (marketed).
Related
- Manufacturer: University of California, San Diego — full pipeline
- Also known as: Retrovir, Epivir, Viramune
- Compare: zidovudine-lamivudine-nevirapine vs similar drugs
- Pricing: zidovudine-lamivudine-nevirapine cost, discount & access